Lam Research Corporation - LRCX

LRCX Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
LRCX	1.4	5.6	3.2	9.8	-17.0	6.7	18.3	160.7	922.9	36035.4
S&P 500	1.0	1.8	-0.9	2.7	7.3	26.5	31.0	80.1	196.5	33856.2

Compare LRCX with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	LRCX
name	Lam Research Corporation
price	80.3
changes percentage	1.3633
change	1.08
day low	79.6
day high	81.81
year high	113
year low	68.87
market cap	103320404000
price avg 50	74.923
price avg 200	85.61143
exchange	NASDAQ
volume	10187648
avg volume	11821695
open	81.47
previous close	79.22
eps	3.09
pe	25.99
earnings announcement	2025-01-29T21:00:00.000+0000
shares outstanding	1286680000
timestamp	2025-01-17 21:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 29.0%

Overall Quarterly Financial Health: 68.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000707549
revenue	14905386000	17428516000	-14.48
gross profit	7052791000	7776925000	-9.31
gross profit ratio	0.47	0.45	6.04
research and development expenses	1902444000	1727162000	10.15
operating expenses	2788878000	2559915000	8.94
interest income	251938000	138984000	81.27
interest expense	185236000	186462000	-0.66
ebitda	4905157000	5637608000	-12.99
ebitdaratio	0.33	0.32	2.39
operating income	4263912999	5174860000	-17.60
operating income ratio	0.29	0.3	-3.66
net income	3827772000	4510931000	-15.14
net income ratio	0.26	0.26	-0.78
eps	2.91	3.33	-12.61

Overall Score of Annual Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 14,905 million in 2024 from 17,429 million in 2023 representing a change of -14.48%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 7,053 million in 2024 from 7,777 million in 2023 representing a change of -9.31%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 2,789 million in 2024 from 2,560 million in 2023 representing a change of 8.94%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 4,905 million in 2024 from 5,638 million in 2023 representing a change of -12.99%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 4,264 million in 2024 from 5,175 million in 2023 representing a change of -17.6%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 3,828 million in 2024 from 4,511 million in 2023 representing a change of -15.14%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 2.91 in 2024 from 2.91 in 2023 representing a change of -12.61%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 1,902 million in 2024 from 1,727 million in 2023 representing a change of 10.15%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000707549
revenue	4167976000	3871507000	7.66
gross profit	2002683000	1849880000	8.26
gross profit ratio	0.48	0.48	0.56
research and development expenses	495358000	497829000	-0.50
operating expenses	738486000	713536000	3.50
interest income	68449000	66027000	3.67
interest expense	44946000	46439000	-3.21
ebitda	1433519000	1224701000	17.05
ebitdaratio	0.34	0.32	8.72
operating income	1264197000	1136344000	11.25
operating income ratio	0.3	0.29	3.34
net income	1116444000	1020282000	9.43
net income ratio	0.27	0.26	1.64
eps	0.86	0.78	10.26

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 4,168 million in 2025Q1 from 3,872 million in 2024Q4 representing a change of 7.66%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 2,003 million in 2025Q1 from 1,850 million in 2024Q4 representing a change of 8.26%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 1,434 million in 2025Q1 from 1,225 million in 2024Q4 representing a change of 17.05%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 1,264 million in 2025Q1 from 1,136 million in 2024Q4 representing a change of 11.25%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 1,116 million in 2025Q1 from 1,020 million in 2024Q4 representing a change of 9.43%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.86 in 2025Q1 from 0.86 in 2024Q4 representing a change of 10.26%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 495 million in 2025Q1 from 498 million in 2024Q4 representing a change of -0.5%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 738 million in 2025Q1 from 714 million in 2024Q4 representing a change of 3.5%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000707549
total assets	18744728000	18781643000	-0.20
total liabilities	10205274000	10571471000	-3.46
total equity	8539454000	8210172000	4.01
cash and cash equivalents	5847856000	5337056000	9.57
short term investments	0	37641000	-100.00
long term investments	0	26208000	-100.00
total current assets	12883220000	13228412000	-2.61
total non current assets	5861508000	5553231000	5.55
total current liabilities	4338438000	4184918000	3.67
total non current liabilities	5866836000	6386553000	-8.14
common stock	130000	133000	-2.26
retained earnings	24811315000	22032096000	12.61
total debt	4983334000	5011541000	-0.56

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 18,745 million in 2024 from 18,782 million in 2023 representing a change of -0.2%. Suggesting a decrease in asset holdings.

  Short Term Investments: Short Term Investments decreased to 0 million in 2024 from 38 million in 2023 representing a change of -100.0%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 12,883 million in 2024 from 13,228 million in 2023 representing a change of -2.61%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 4,338 million in 2024 from 4,185 million in 2023 representing a change of 3.67%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 0 in 2024 from 0 in 2023 representing a change of -2.26%. This indicates a decrease in ownership interest.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 10,205 million in 2024 from 10,571 million in 2023 representing a change of -3.46%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 8,539 million in 2024 from 8,210 million in 2023 representing a change of 4.01%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 5,848 million in 2024 from 5,337 million in 2023 representing a change of 9.57%. This indicates an increase in available liquid assets.

  Retained Earnings: Retained Earnings increased to 24,811 million in 2024 from 22,032 million in 2023 representing a change of 12.61%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 4,983 million in 2024 from 5,012 million in 2023 representing a change of -0.56%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000707549
total assets	19532489000	18744728000	4.20
total liabilities	11060598000	10205274000	8.38
total equity	8471891000	8539454000	-0.79
cash and cash equivalents	6067471000	5847856000	3.76
short term investments	0	0	NaN
long term investments	4613000	2947000	56.53
total current assets	13492368000	12883220000	4.73
total non current assets	6040121000	5861508000	3.05
total current liabilities	5342668000	4338438000	23.15
total non current liabilities	5717930000	5866835999	-2.54
common stock	1292000	130000	893.85
retained earnings	25630045000	24811315000	3.30
total debt	4983769000	4983334000	0.01

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 19,532 million in 2025Q1 from 18,745 million in 2024Q4 representing a change of 4.2%. Suggesting a growth in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 6,067 million in 2025Q1 from 5,848 million in 2024Q4 representing a change of 3.76%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 13,492 million in 2025Q1 from 12,883 million in 2024Q4 representing a change of 4.73%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 1 in 2025Q1 from 0 in 2024Q4 representing a change of 893.85%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 25,630 million in 2025Q1 from 24,811 million in 2024Q4 representing a change of 3.3%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 11,061 million in 2025Q1 from 10,205 million in 2024Q4 representing a change of 8.38%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 8,472 million in 2025Q1 from 8,539 million in 2024Q4 representing a change of -0.79%. This indicates a decrease in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities increased to 5,343 million in 2025Q1 from 4,338 million in 2024Q4 representing a change of 23.15%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 4,984 million in 2025Q1 from 4,983 million in 2024Q4 representing a change of 0.01%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000707549
net change in cash	263431000	1813837000	-85.48
operating cash flow	4652269000	5178938000	-10.17
free cash flow	4255599000	4677370000	-9.02
capital expenditure	-396670000	-501568000	20.91
depreciation and amortization	359699000	342432000	5.04
deferred income tax	-198981000	-172061000	-15.65
stock based compensation	293058000	286600000	2.25
accounts payables	125939000	-522200000	124.12
inventory	528723000	-961968000	154.96
acquisitions net	0	-119955000	100.00
investments in property plant and equipment	-396670000	-501568000	20.91
net cash used for investing activites	-370614000	-534562000	30.67
debt repayment	-256104000	-23206000	-1003.61
common stock issued	0	11111000	-100.00
common stock repurchased	-2842807000	-2017012000	-40.94
dividends paid	-1018915000	-907907000	-12.23
net cash used provided by financing activities	-3995850000	-2830667000	-41.16
cash at end of period	5850803000	5587372000	4.71
accounts receivables	303443000	1452256000	-79.11
cash at beginning of period	5587372000	3773535000	48.07

Overall Score of Annual Cashflow Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 263 million in 2024 from 1,814 million in 2023 representing a change of -85.48%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 4,652 million in 2024 from 5,179 million in 2023 representing a change of -10.17%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 4,256 million in 2024 from 4,677 million in 2023 representing a change of -9.02%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -397 million in 2024 from -502 million in 2023 representing a change of 20.91%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 293 million in 2024 from 287 million in 2023 representing a change of 2.25%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -1,019 million in 2024 from -908 million in 2023 representing a change of -12.23%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Accounts Payables: The absolute value of Accounts Payables decreased to 126 million in 2024 from 522 million in 2023 representing a change of 124.12%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 303 million in 2024 from 1,452 million in 2023 representing a change of -79.11%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2025Q1	2024Q4	Q/Q change %
0000707549
operating cash flow	1568471000	862430000	81.87
free cash flow	1457883000	761682000	91.40
capital expenditure	-110588000	-100748000	-9.77
depreciation and amortization	94295000	88357000	6.72
deferred income tax	-108722000	-61375000	-77.14
stock based compensation	80011000	79092000	1.16
accounts receivables	0	-614500000	100.00
accounts payables	0	-80263000	100.00
inventory	0	-405714000	100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-110588000	-100748000	-9.77
net cash used for investing activites	-110551000	-101613000	-8.80
debt repayment	-934000	-97987000	99.05
common stock issued	-43000	2796000	-101.54
common stock repurchased	-997035000	-373550000	-166.91
dividends paid	-260985000	-261462000	0.18
net cash used provided by financing activities	-1259321000	-574151000	-119.34
net change in cash	221281000	175624000	26.00
cash at end of period	6072084000	5847856000	3.83
cash at beginning of period	5850803000	5672232000	3.15

Overall Score of Quarterly Cashflow Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 221 million in 2025Q1 from 176 million in 2024Q4 representing a change of 26.0%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 1,568 million in 2025Q1 from 862 million in 2024Q4 representing a change of 81.87%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 1,458 million in 2025Q1 from 762 million in 2024Q4 representing a change of 91.4%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -111 million in 2025Q1 from -101 million in 2024Q4 representing a change of -9.77%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2025Q1 from 80 million in 2024Q4 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid increased to -261 million in 2025Q1 from -261 million in 2024Q4 representing a change of 0.18%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Stock-Based Compensation: Stock-Based Compensation increased to 80 million in 2025Q1 from 79 million in 2024Q4 representing a change of 1.16%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 0 in 2025Q1 from -614 million in 2024Q4 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q1 2025 Earnings call transcript
Q4 2024 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-06-30	2023-06-25	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	11.34	12.87	-11.83
net income per share	2.91	3.33	-12.52
operating cash flow per share	3.54	3.82	-7.39
free cash flow per share	3.24	3.45	-6.20
cash per share	4.45	3.97	12.17
book value per share	6.5	6.06	7.23
tangible book value per share	5.16	4.74	8.79
shareholders equity per share	6.5	6.06	7.23
interest debt per share	3.93	3.84	2.51
market cap	139373446000	84033281600	65.86
enterprise value	138508924000	83707766600	65.47
pe ratio	36.41	18.63	95.46
price to sales ratio	9.35	4.82	93.93
pocfratio	29.96	16.23	84.63
pfcf ratio	32.75	17.97	82.29
pb ratio	16.32	10.24	59.46
ptb ratio	16.32	10.24	59.46
ev to sales	9.29	4.8	93.48
enterprise value over ebitda	28.24	14.85	90.18
ev to operating cash flow	29.77	16.16	84.20
ev to free cash flow	32.55	17.9	81.87
earnings yield	0.03	0.05	-48.84
free cash flow yield	0.03	0.06	-45.14
debt to equity	0.58	0.61	-4.40
debt to assets	0.27	0.27	-0.37
net debt to ebitda	-0.18	-0.06	-205.24
current ratio	2.97	3.16	-6.06
interest coverage	23.02	27.75	-17.06
income quality	1.22	1.15	5.86
dividend yield	0.01	0.01	-32.33
payout ratio	0.27	0.2	32.26
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.13	0.1	28.79
intangibles to total assets	0.09	0.1	-1.25
capex to operating cash flow	0.09	0.1	-11.96
capex to revenue	0.03	0.03	-7.53
capex to depreciation	1.1	1.46	-24.71
stock based compensation to revenue	0.02	0.02	19.56
graham number	20.64	21.31	-3.15
roic	0.25	0.31	-19.75
return on tangible assets	0.23	0.27	-15.09
graham net net	-0.27	-0.5	44.85
working capital	8544782000	9043494000	-5.51
tangible asset value	6774381000	6419229000	5.53
net current asset value	2677946000	2656941000	0.79
invested capital	12772709000	12691109000	0.64
average receivables	2671313000	3568597000	-25.14
average payables	542334000	740955000	-26.81
average inventory	4517057000	4391242000	2.87
days sales outstanding	61.69	59.13	4.33
days payables outstanding	28.54	17.8	60.32
days of inventory on hand	196.06	182.14	7.64
receivables turnover	5.92	6.17	-4.15
payables turnover	12.79	20.5	-37.62
inventory turnover	1.86	2.0	-7.10
roe	0.45	0.55	-18.42
capex per share	0.3	0.37	-18.47

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.45 on 2024-06-30 from 0.55 on 2023-06-25, representing a change of -18.42%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

  Current Ratio: Current Ratio decreased to 2.97 on 2024-06-30 from 3.16 on 2023-06-25, representing a change of -6.06%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 36.41 on 2024-06-30 from 18.63 on 2023-06-25, representing a change of 95.46%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.58 on 2024-06-30 from 0.61 on 2023-06-25, representing a change of -4.40%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-29 Q1	2024-06-30 Q4	Q/Q change %
LRCX
calendar year	2025	2024	NaN
revenue per share	3.21	2.96	8.25
net income per share	0.86	0.78	10.02
operating cash flow per share	1.21	0.66	82.86
free cash flow per share	1.12	0.58	92.45
cash per share	4.67	4.48	4.32
book value per share	6.52	6.54	-0.25
tangible book value per share	5.17	5.19	-0.36
shareholders equity per share	6.52	6.54	-0.25
interest debt per share	3.87	3.85	0.52
market cap	106030649960	138549359800	-23.47
enterprise value	104946947960	137684837800	-23.78
pe ratio	23.74	33.95	-30.06
price to sales ratio	25.44	35.79	-28.91
pocfratio	67.6	160.65	-57.92
pfcf ratio	72.73	181.9	-60.02
pb ratio	12.52	16.22	-22.86
ptb ratio	12.52	16.22	-22.86
ev to sales	25.18	35.56	-29.20
enterprise value over ebitda	73.21	112.42	-34.88
ev to operating cash flow	66.91	159.65	-58.09
ev to free cash flow	71.99	180.76	-60.18
earnings yield	0.01	0.01	42.98
free cash flow yield	0.01	0.01	150.10
debt to equity	0.59	0.58	0.81
debt to assets	0.26	0.27	-4.02
net debt to ebitda	-0.76	-0.71	-7.09
current ratio	2.53	2.97	-14.96
interest coverage	28.13	24.47	14.95
income quality	1.4	0.85	66.20
dividend yield	0.0	0.0	30.43
payout ratio	0.23	0.26	-8.78
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.12	0.13	-7.57
intangibles to total assets	0.09	0.09	-4.40
capex to operating cash flow	0.07	0.12	-39.64
capex to revenue	0.03	0.03	1.96
capex to depreciation	1.17	1.14	2.85
stock based compensation to revenue	0.02	0.02	-6.03
graham number	11.23	10.72	4.76
roic	0.07	0.07	10.18
return on tangible assets	0.06	0.06	4.53
graham net net	-0.53	-0.27	-91.92
working capital	8149700000	8544782000	-4.62
tangible asset value	6713547000	6774381000	-0.90
net current asset value	2431770000	2677946000	-9.19
invested capital	12122313000	12464373000	-2.74
average receivables	2728233500	2361478500	15.53
average payables	659106500	572807000	15.07
average inventory	4213901000	4270445500	-1.32
days sales outstanding	63.42	58.56	8.30
days payables outstanding	29.27	27.33	7.09
days of inventory on hand	174.98	187.78	-6.81
receivables turnover	1.42	1.54	-7.66
payables turnover	3.07	3.29	-6.62
inventory turnover	0.51	0.48	7.31
roe	0.13	0.12	10.30
capex per share	0.09	0.08	10.37

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 23.74 on 2024-09-29 Q1 from 33.95 on 2024-06-30 Q4, representing a change of -30.06%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 2.53 on 2024-09-29 Q1 from 2.97 on 2024-06-30 Q4, representing a change of -14.96%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.59 on 2024-09-29 Q1 from 0.58 on 2024-06-30 Q4, representing a change of 0.81%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 53.3 which is lower than current price 80.3, indicates the company may be overvalued.